VitaNova Life Sciences Corp
corporate_fare Company Profile
VitaNova Life Sciences Corp (OTC:VNOV) is a publicly traded company in the Trade & Services sector. Wiseek monitors VNOV SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- VitaNova Reports Q3 Loss, Strong Revenue Growth, and Material Weaknesses in Internal Controls
Financial Snapshot
Fiscal year ended April 30, 2025
Revenue
$2.66M
Net Income
$850.75K
Diluted EPS
$0.03
Op. Cash Flow
$192.77K
Gross Profit
$1.58M
Operating Income
$1.21M
Cash & Equivalents
$782.81K
Debt / Equity
0.00×
Net Margin
32.0%
Shares Outstanding
25.01M sh
Source: 10-K · filed 2025-07-24 · accession 0001683168-25-005368
show_chartPrice Chart
Loading chart...
feed VNOV - Latest Insights
VNOV
Mar 16, 2026, 5:00 PM EDT
Price at Filing:
$4.83
Real-time Price:
$1.38
Change:
-$3.45 (-71%)
Market Cap:
$11.506M